Search Results - "Royal, Joshua M"
-
1
Cholera toxin B: one subunit with many pharmaceutical applications
Published in Toxins (20-03-2015)“…Cholera, a waterborne acute diarrheal disease caused by Vibrio cholerae, remains prevalent in underdeveloped countries and is a serious health threat to those…”
Get full text
Journal Article Book Review -
2
Therapeutic Potential of Cholera Toxin B Subunit for the Treatment of Inflammatory Diseases of the Mucosa
Published in Toxins (23-11-2017)“…Cholera toxin B subunit (CTB) is a mucosal immunomodulatory protein that induces robust mucosal and systemic antibody responses. This well-known biological…”
Get full text
Journal Article -
3
Isolation and detection of a KDEL-tagged recombinant cholera toxin B subunit from Nicotiana benthamiana
Published in Process biochemistry (1991) (01-02-2021)“…[Display omitted] •A novel mucosal wound-healing protein (CTBSEKDEL) was produced in plants.•C-terminally truncated byproducts were removed by ceramic…”
Get full text
Journal Article -
4
A modified cholera toxin B subunit containing an ER retention motif enhances colon epithelial repair via an unfolded protein response
Published in The FASEB journal (01-12-2019)“…Cholera toxin B subunit (CTB) exhibits broad‐spectrum biologic activity upon mucosal administration. Here, we found that a recombinant CTB containing an…”
Get full text
Journal Article -
5
Repeated Oral Administration of a KDEL-tagged Recombinant Cholera Toxin B Subunit Effectively Mitigates DSS Colitis Despite a Robust Immunogenic Response
Published in Toxins (20-11-2019)“…Cholera toxin B subunit (CTB), a non-toxic homopentameric component of holotoxin, is an oral cholera vaccine antigen that induces an anti-toxin antibody…”
Get full text
Journal Article -
6
Development of a SARS-CoV-2 Vaccine Candidate Using Plant-Based Manufacturing and a Tobacco Mosaic Virus-like Nano-Particle
Published in Vaccines (Basel) (17-11-2021)“…Stable, effective, easy-to-manufacture vaccines are critical to stopping the COVID-19 pandemic resulting from the coronavirus SARS-CoV-2. We constructed a…”
Get full text
Journal Article -
7
Spray-Dried Formulation of Epicertin, a Recombinant Cholera Toxin B Subunit Variant That Induces Mucosal Healing
Published in Pharmaceutics (18-04-2021)“…Epicertin (EPT) is a recombinant variant of the cholera toxin B subunit, modified with a C-terminal KDEL endoplasmic reticulum retention motif. EPT has…”
Get full text
Journal Article -
8
CoV-RBD121-NP Vaccine Candidate Protects against Symptomatic Disease following SARS-CoV-2 Challenge in K18-hACE2 Mice and Induces Protective Responses That Prevent COVID-19-Associated Immunopathology
Published in Vaccines (Basel) (17-11-2021)“…We developed a SARS-CoV-2 vaccine candidate (CoV-RBD121-NP) comprised of a tobacco mosaic virus-like nanoparticle conjugated to the receptor-binding domain of…”
Get full text
Journal Article -
9
Oral Administration of a Cholera Vaccine Antigen Facilitates Colonic Mucosal Healing in a Murine Model of Colitis
Published in Gastroenterology (New York, N.Y. 1943) (01-04-2017)Get full text
Journal Article -
10
-
11
P032 EPICERTIN ENHANCES INTESTINAL WOUND HEALING IN A MOUSE COLITIS MODEL AND HUMAN ULCERATIVE COLITIS COLON EXPLANTS
Published in Gastroenterology (New York, N.Y. 1943) (01-01-2018)Get full text
Journal Article -
12
P032 EPICERTIN ENHANCES INTESTINAL WOUND HEALING IN A MOUSE COLITIS MODEL AND HUMAN ULCERATIVE COLITIS COLON EXPLANTS
Published in Inflammatory bowel diseases (18-01-2018)“…Abstract Epicertin (EPT) is a new ulcerative colitis (UC) drug candidate derived from the nontoxic component of Vibrio cholerae cholera toxin. We have recently…”
Get full text
Journal Article -
13
Su1856 - Oral Administration of a Cholera Vaccine Antigen Facilitates Colonic Mucosal Healing in a Murine Model of Colitis
Published in Gastroenterology (New York, N.Y. 1943) (01-04-2017)Get full text
Journal Article